desoxycorticosterone acetate has been researched along with Cardiomegaly in 8 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Desoxycorticosterone acetate (DCA) and NaCl, in the dosage employed in normal rats, caused renal and cardiac hypertrophy, characteristic changes in the renal tubular epithelium, atrophic changes in the subcapsular zone of the adrenal cortex, and serum electrolyte changes characterized by a rise in sodium and fall in potassium." | 3.63 | DESOXYCORTICOSTERONE ACETATE : THE POTENTIATION OF ITS ACTIVITY BY SODIUM CHLORIDE. ( Knowlton, AI; Loeb, EN; Seegal, BC; Stoerk, HC, 1947) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, H | 2 |
| Tang, LX | 2 |
| Wang, XM | 2 |
| Li, LP | 2 |
| Chen, XK | 2 |
| He, YJ | 2 |
| Yang, DZ | 2 |
| Shi, Y | 2 |
| Shou, JL | 2 |
| Zhang, ZS | 2 |
| Wang, L | 2 |
| Lu, BJ | 2 |
| An, SM | 2 |
| Zeng, CY | 2 |
| Wang, WE | 2 |
| Samuelsson, AM | 1 |
| Bartolomaeus, TUP | 1 |
| Anandakumar, H | 1 |
| Thowsen, I | 1 |
| Nikpey, E | 1 |
| Han, J | 1 |
| Marko, L | 1 |
| Finne, K | 1 |
| Tenstad, O | 1 |
| Eckstein, J | 1 |
| Berndt, N | 1 |
| Kühne, T | 1 |
| Kedziora, S | 1 |
| Sultan, I | 1 |
| Skogstrand, T | 1 |
| Karlsen, TV | 1 |
| Nurmi, H | 1 |
| Forslund, SK | 1 |
| Bollano, E | 1 |
| Alitalo, K | 1 |
| Muller, DN | 1 |
| Wiig, H | 1 |
| Cao, HJ | 1 |
| Fang, J | 1 |
| Zhang, YL | 2 |
| Zou, LX | 1 |
| Han, X | 1 |
| Yang, J | 1 |
| Yan, X | 1 |
| Li, PB | 1 |
| Wang, HX | 2 |
| Guo, SB | 1 |
| Li, HH | 2 |
| Wang, F | 1 |
| Sun, Y | 1 |
| Luo, R | 1 |
| Lu, X | 1 |
| Yang, B | 1 |
| Yang, T | 1 |
| Alogna, A | 1 |
| Schwarzl, M | 1 |
| Manninger, M | 1 |
| Hamdani, N | 1 |
| Zirngast, B | 1 |
| Kloth, B | 1 |
| Steendijk, P | 1 |
| Verderber, J | 1 |
| Zweiker, D | 1 |
| Westermann, D | 1 |
| Blankenberg, S | 1 |
| Maechler, H | 1 |
| Tschöpe, C | 1 |
| Linke, WA | 1 |
| Marsche, G | 1 |
| Pieske, BM | 1 |
| Post, H | 1 |
| Liu, S | 1 |
| Liu, LX | 1 |
| Lai, S | 1 |
| Xie, YP | 1 |
| Li, NN | 1 |
| Xia, YL | 1 |
| Liu, Y | 1 |
| Kee, HJ | 1 |
| Bae, EH | 1 |
| Park, S | 1 |
| Lee, KE | 1 |
| Suh, SH | 1 |
| Kim, SW | 1 |
| Jeong, MH | 1 |
| Knowlton, AI | 1 |
| Loeb, EN | 1 |
| Stoerk, HC | 1 |
| Seegal, BC | 1 |
8 other studies available for desoxycorticosterone acetate and Cardiomegaly
| Article | Year |
|---|---|
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
Topics: Animals; Cardiomegaly; Desoxycorticosterone Acetate; Heart Failure; Heart Failure, Systolic; Hyperte | 2023 |
Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice.
Topics: Animals; Cardiomegaly; Chymotrypsin; Desoxycorticosterone Acetate; Fibrosis; Hypertension; Inflammat | 2019 |
COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
Topics: Animals; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Desoxycorticosterone Acetate; Disease Model | 2020 |
Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo.
Topics: Animals; Blood Pressure; Cardiomegaly; Connectin; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; | 2018 |
Cardiac Ablation of SOCS3 Aggravates DOCA-Salt-Induced Hypertrophic Remodeling by Activation of Gp130-Dependent Signaling in Mice.
Topics: Animals; Cardiomegaly; Cytokine Receptor gp130; Desoxycorticosterone Acetate; Gene Deletion; Male; M | 2018 |
HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activity.
Topics: Animals; Cardiomegaly; Desoxycorticosterone Acetate; Disease Models, Animal; Enzyme Activation; Fibr | 2013 |
DESOXYCORTICOSTERONE ACETATE : THE POTENTIATION OF ITS ACTIVITY BY SODIUM CHLORIDE.
Topics: Adrenal Glands; Animals; Cardiomegaly; Desoxycorticosterone; Desoxycorticosterone Acetate; Hypertens | 1947 |